Price:
Rs. 16,800.00
Sample Type: BLOOD
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What is the Cell-Free DNA EGFR Test?
It is a liquid biopsy at Metropolis Healthcare that detects EGFR mutations (DEL19, L858R, T790M) in circulating tumor DNA from blood.
Who should consider this test?
Patients with non-small cell lung cancer (NSCLC) or those suspected of harboring EGFR mutations may benefit, especially for therapy selection.
What sample is required for this test?
A blood sample is collected for cfDNA extraction and molecular analysis at Metropolis Healthcare.
Is fasting required for this test?
No fasting is needed. The test can be performed without special preparation.
How accurate are the results from Metropolis Healthcare?
Metropolis uses highly sensitive molecular platforms to ensure reliable detection of EGFR mutations in circulating DNA.
Can this test replace tissue biopsy?
It is a non-invasive alternative for detecting EGFR mutations when tissue biopsy is unavailable or risky, but tissue biopsy remains the gold standard for initial diagnosis.
How can the results help in treatment planning?
Identifying EGFR mutations guides the use of targeted therapies, such as tyrosine kinase inhibitors, improving treatment outcomes.
How soon are the results available?
Results are typically available within 5–7 days, depending on laboratory processing at Metropolis Healthcare.